Specialty medical injectable medication program, requirement and policy updates May 2025

Review the following tables to determine changes to our specialty medical injectable medication programs and drug policy updates for May 2025.

May 9, 2025

Review at launch

The following specialty medical injectable medications have been added to Review at Launch:

Medication Name HCPCs Code(s)
Azmiro™
(testosterone cypionate)

J1072
Qfitlia™
(fitusiran)		 J3490/J3590/C9399

Note: Medications added to Review at Launch may not yet be available in the marketplace.

Review the UnitedHealthcare Commercial Plan Review at Launch Medication List.

For questions, please contact your broker or UnitedHealthcare representative.

 

More articles

Employer Page template - More news Experience Fragment

Current employer group client or broker?

Access uhceservices to manage eligibility, view plan documents, request ID cards and more.

Sign in